| Name | Visionworks |
|---|---|
| Organization Name | Visionworks Inc |
| Location | 2b Haw Creek Ln, Asheville, North Carolina 28805 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (828) 298-0207 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In the United States, more than 100,000 amputations are performed each year on individuals with critical limb ischemia, the most severe form of peripheral arterial disease (PAD). The number one priority in treating these patients is to re-establish blood flow to avoid limb amputation.
"Three" kinds of regalia such as crown, orb, and sward are often necessary to be a high king for conquering the world. For fighting off cancerous diseases, what do we need? This "triple" chemical modified nanomaterial might be save the patient.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
A seven-member state committee holds the fate of Ohio's Medicaid expansion in its hands as it prepares to vote on the proposal, and no one is talking about how they plan to vote.
Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.
› Verified 8 days ago
| NPI Number | 1427335033 |
| Organization Name | VISIONWORKS, INC. |
| Doing Business As | VISIONWORKS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 2b Haw Creek Ln, Asheville, NC 28805 |
| Phone Number | 828-298-0207 |
News Archive
In the United States, more than 100,000 amputations are performed each year on individuals with critical limb ischemia, the most severe form of peripheral arterial disease (PAD). The number one priority in treating these patients is to re-establish blood flow to avoid limb amputation.
"Three" kinds of regalia such as crown, orb, and sward are often necessary to be a high king for conquering the world. For fighting off cancerous diseases, what do we need? This "triple" chemical modified nanomaterial might be save the patient.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
A seven-member state committee holds the fate of Ohio's Medicaid expansion in its hands as it prepares to vote on the proposal, and no one is talking about how they plan to vote.
Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.
› Verified 8 days ago
| NPI Number | 1497836514 |
| Organization Name | VISIONWORKS INC |
| Doing Business As | VISIONWORKS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 2 B Haw Creek Lane, Asheville, NC 28805 |
| Phone Number | 828-298-0207 |
News Archive
In the United States, more than 100,000 amputations are performed each year on individuals with critical limb ischemia, the most severe form of peripheral arterial disease (PAD). The number one priority in treating these patients is to re-establish blood flow to avoid limb amputation.
"Three" kinds of regalia such as crown, orb, and sward are often necessary to be a high king for conquering the world. For fighting off cancerous diseases, what do we need? This "triple" chemical modified nanomaterial might be save the patient.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
A seven-member state committee holds the fate of Ohio's Medicaid expansion in its hands as it prepares to vote on the proposal, and no one is talking about how they plan to vote.
Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.
› Verified 8 days ago
| NPI Number | 1699491605 |
| Organization Name | NC DOCTORS OF OPTOMETRY PLLC |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 83 S Tunnel Rd Ste A2, Asheville, NC 28805 |
| Phone Number | 828-298-0207 |
News Archive
In the United States, more than 100,000 amputations are performed each year on individuals with critical limb ischemia, the most severe form of peripheral arterial disease (PAD). The number one priority in treating these patients is to re-establish blood flow to avoid limb amputation.
"Three" kinds of regalia such as crown, orb, and sward are often necessary to be a high king for conquering the world. For fighting off cancerous diseases, what do we need? This "triple" chemical modified nanomaterial might be save the patient.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
A seven-member state committee holds the fate of Ohio's Medicaid expansion in its hands as it prepares to vote on the proposal, and no one is talking about how they plan to vote.
Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.
› Verified 8 days ago
News Archive
In the United States, more than 100,000 amputations are performed each year on individuals with critical limb ischemia, the most severe form of peripheral arterial disease (PAD). The number one priority in treating these patients is to re-establish blood flow to avoid limb amputation.
"Three" kinds of regalia such as crown, orb, and sward are often necessary to be a high king for conquering the world. For fighting off cancerous diseases, what do we need? This "triple" chemical modified nanomaterial might be save the patient.
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
A seven-member state committee holds the fate of Ohio's Medicaid expansion in its hands as it prepares to vote on the proposal, and no one is talking about how they plan to vote.
Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.
› Verified 8 days ago
Accucare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: One Resort Drive, Asheville, North Carolina 28806 Phone: (828) 236-3100 | |
Asheville Discount Pharmacy Inc Type: Pharmacy Location: 76 Patton Ave, Asheville, North Carolina 28801 Phone: (828) 258-8511 | |
Asheville Eye Asso Pllc Type: Medicare Supplier Location: 8 Medical Park Dr, Asheville, North Carolina 28803 Phone: (828) 258-1586 | |
Ability Prosthetics & Orthotics, In Type: Prosthetic/Orthotic Supplier Location: 3 Walden Ridge Dr, Asheville, North Carolina 28803 Phone: (828) 252-0331 | |
Blue Ridge Home Care Type: DME Supplier - Parenteral & Enteral Nutrition Location: 101 Caribou Rd, Asheville, North Carolina 28803 Phone: (828) 274-7587 |